prednisone has been researched along with Histiocytoma, Benign Fibrous in 5 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
Excerpt | Relevance | Reference |
---|---|---|
"Prednisone 15 mg/day was reintroduced and hydroxychloroquine stopped being a possible cause of the facial hyperpigmented macules." | 1.31 | Multiple eruptive dermatofibromas in patients with systemic lupus erythematosus treated with prednisone. ( Massone, C; Parodi, A; Rebora, A; Virno, G, 2002) |
"In a young woman with multiple malignant fibrous histiocytoma of bone and soft tissue with a rapidly progressive course, long-term chemotherapy with prednisone and cyclophosphamide resulted in a complete remission still lasting after an 11-year follow-up." | 1.27 | Chemotherapy-induced complete remission of a malignant fibrous histiocytoma of bone. An 11-year follow-up. ( Cottier, H; Reubi, FC; Schaeffeler, K, 1986) |
"Inflammatory fibrous histiocytoma is a recently recognized variant of malignant fibrous histiocytoma." | 1.26 | Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapy. ( Chang-Poon, VY; Durant, JR; Norgard, MJ; Poon, MC, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, BG | 1 |
Liang, H | 1 |
Cui, QH | 1 |
Wang, JC | 1 |
Liu, JZ | 1 |
Milman, T | 1 |
Finger, PT | 1 |
Iacob, C | 1 |
Garcia, JP | 1 |
Della Rocca, DA | 1 |
McCormick, SA | 1 |
Poon, MC | 1 |
Durant, JR | 1 |
Norgard, MJ | 1 |
Chang-Poon, VY | 1 |
Massone, C | 1 |
Parodi, A | 1 |
Virno, G | 1 |
Rebora, A | 1 |
Reubi, FC | 1 |
Cottier, H | 1 |
Schaeffeler, K | 1 |
5 other studies available for prednisone and Histiocytoma, Benign Fibrous
Article | Year |
---|---|
[Malignant fibrous histiocytoma of the retroperitoneum: an analysis of 31 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamid | 2004 |
Fibrous histiocytoma.
Topics: Biomarkers, Tumor; Corneal Diseases; Eye Neoplasms; Female; Glucocorticoids; Histiocytoma, Benign Fi | 2007 |
Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combina | 1982 |
Multiple eruptive dermatofibromas in patients with systemic lupus erythematosus treated with prednisone.
Topics: Anti-Inflammatory Agents; Drug Eruptions; Female; Histiocytoma, Benign Fibrous; Humans; Lupus Erythe | 2002 |
Chemotherapy-induced complete remission of a malignant fibrous histiocytoma of bone. An 11-year follow-up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Female; Fol | 1986 |